Actinium Pharmaceuticals, Inc. quarterly report, Q3 FY2008

SEC Filing Summary: Cactus Ventures, Inc. (10-Q)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2008, and the nine-month period then ended. The registrant is Cactus Ventures, Inc., a Nevada corporation and shell company with no active operations. The company is seeking a merger or acquisition with a target business entity to become a public reporting company. It has no employees, no owned property, and utilizes office space at the President's residence at no cost.

Key Financial Metrics

Metric Nine Months Ended Sep 30, 2008 Nine Months Ended Sep 30, 2007
Revenue $0 $0
Net Loss $(23,631) $(10,163)
Operating Expenses $20,103 $7,493
Interest Expense $3,528 $2,670
Cash and Cash Equivalents (Sep 30, 2008) $2,242 N/A
Total Liabilities (Sep 30, 2008) $68,591 $45,032 (Dec 31, 2007)
Shareholders' Deficit (Sep 30, 2008) $(66,349) $(42,717) (Dec 31, 2007)
Working Capital Deficiency $(19,522) N/A

Material Changes vs. Prior Period

  • Increased Losses: The net loss for the nine months ended September 30, 2008, increased to $23,631 from $10,163 in the prior year period. This was driven by a rise in operating expenses from $7,493 to $20,103, primarily due to higher professional fees ($12,840 vs. $6,505) and other costs.
  • Liability Growth: Total liabilities increased significantly from $45,032 at year-end 2007 to $68,591 at September 30, 2008. This includes a rise in notes payable to related parties from $35,959 to $46,827 and accrued interest from $3,678 to $7,206.
  • Cash Position: Cash on hand decreased slightly from $2,314 at December 31, 2007, to $2,242 at September 30, 2008.

Outlook, Risks, and Contingencies

Going Concern: The filing explicitly states that the company's independent auditors have expressed substantial doubt about its ability to continue as a going concern. This is due to the accumulated deficit, negative working capital, and lack of revenue. Continuation is dependent on raising additional funds and successfully implementing a business plan (merger/acquisition).

Financing Needs: The company anticipates needing additional capital to meet liquidity needs. It plans to rely on contributions from shareholders, loans from officers/directors, or the sale of common stock. There are no binding agreements for future funding.

Risk Factors:

  • Speculative Nature: No assurance exists that the company will identify or consummate a business combination.
  • Management Limitations: Management devotes limited time to the company, and the sole officer has no written employment agreement.
  • Stock Liquidity: The stock is subject to "Penny Stock" rules, which may severely restrict resale and liquidity.
  • Competition: The company faces significant competition from better-funded entities in the search for acquisition targets.

Investor Verification Checklist

  • Capital Sufficiency: Verify if the company has secured the shareholder contributions or loans necessary to cover the $19,522 working capital deficiency and ongoing operating costs.
  • Related Party Debt: Review the terms of the $46,827 in notes payable to related parties to understand repayment obligations and interest rates.
  • Merger Progress: Confirm if any specific target companies are currently under negotiation, as the business model relies entirely on a future acquisition.
  • Legal Compliance: Ensure the company remains current on SEC reporting obligations despite its shell status and financial constraints.